Abstract

In patients with cancer, SARS-CoV-2 (COVID-19) can contribute to increasing morbidity and mortality and decreased survival was found in patients with hematological and intrathoracic malignancies, poor performance status, comorbidities, and increased age. Patients with hematological malignancies who were treated with stem cell transplantation and anti-CD-20 antibody demonstrated lower rates of seroconversion, compared to COVID-19-infected-cancer patients. Patients with hematological malignancies might have substantially compromised B-cell and T-cell responses.

Full Text

Published Version
Open DOI Link

Topics from this Paper

  • Hematological Malignancies
  • Intrathoracic Malignancies
  • Poor Performance Status
  • Stem Cell Transplantation
  • T-cell Responses
    • + Show 5 more

Create a personalized feed of these topics

Get Started

Get access to 115M+ research papers

Discover from 40M+ Open access, 2M+ Pre-prints, 9.5M Topics and 32K+ Journals.

Sign Up Now! It's FREE

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Prioritization of Covid-19 Vaccination in Patients with Cancer
  • International Journal of Cancer Research & Therapy
  • Oct 22, 2021
Relevant
Not Relevant
Seroconversion rates following COVID-19 vaccination among patients with cancer
  • Cancer Cell
  • Aug 1, 2021
Relevant
Not Relevant
Acute respiratory failure in immunocompromised adults
  • The Lancet Respiratory Medicine
  • Feb 1, 2019
Relevant
Not Relevant
Case Selection in the Management of Cerebral Metastases
  • Clinical Oncology
  • Oct 1, 2003
Relevant
Not Relevant
Statistical Correlations Between Quantifiable Disease Variables and Prognosis in Hematological Malignancy Patients Treated with Itraconazole as An Empirical Antifungal Therapy: A Prospective Multicenter Observational Study in Korea
  • Blood
  • Nov 16, 2008
Relevant
Not Relevant
Blunted humoral response after mRNA vaccine in patients with haematological malignancies
  • The Lancet Haematology
  • Aug 1, 2021
Relevant
Not Relevant
EBMT Risk Score Predicts Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Who Have Failed a Previous Transplantation Procedure
  • Biology of Blood and Marrow Transplantation
  • Feb 1, 2012
Relevant
Not Relevant
Editor's evaluation: Study of efficacy and longevity of immune response to third and fourth doses of COVID-19 vaccines in patients with cancer: A single arm clinical trial
  • Feb 9, 2023
Relevant
Not Relevant
Author response: Study of efficacy and longevity of immune response to third and fourth doses of COVID-19 vaccines in patients with cancer: A single arm clinical trial
  • Feb 27, 2023
Relevant
Not Relevant
Decision letter: Study of efficacy and longevity of immune response to third and fourth doses of COVID-19 vaccines in patients with cancer: A single arm clinical trial
  • Feb 9, 2023
Relevant
Not Relevant
Immunogenicity and clinical efficacy of anti‐SARS‐CoV‐2 vaccination in patients with hematological malignancies: Results of a prospective cohort study of 365 patients
  • American Journal of Hematology
  • Jun 24, 2022
Relevant
Not Relevant
Relevance and Clinical Implications of Tumor Cell Mobilization in the Autologous Transplant Setting
  • Biology of Blood and Marrow Transplantation
  • Jul 1, 2011
Relevant
Not Relevant
Pegfilgrastim compared with Filgrastim after autologous hematopoietic peripheral blood stem cell transplantation
  • Experimental Hematology
  • Mar 1, 2006
Relevant
Not Relevant
Epidemiology of Second Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Relapsed Myelodysplastic Syndrome
  • Blood
  • Nov 29, 2018
Relevant
Not Relevant
Clinical Outcomes and Prognostic Factors of Empirical Antifungal Therapy with Itraconazole in the Patients with Hematological Malignancies: A Prospective Multicenter Observational Study in Korea
  • Yonsei Medical Journal
  • Jan 1, 2014
Relevant
Not Relevant
READ MORE FROM

Journal of Bioscience & Biomedical Engineering

Enhancing Patient Autonomy in Home Hemodialysis: Innovations in 3D Printed Aids for Independent Tubing Connection
Open Access
  • Journal of Bioscience & Biomedical Engineering
  • Sep 16, 2023
Relevant
Not Relevant
Robots: Aware Headway and Viable Recovery
Open Access
  • Journal of Bioscience & Biomedical Engineering
  • Nov 26, 2021
Relevant
Not Relevant
Hypogammaglobulinemia as a Predictive Factor of Postoperative Complications in Pediatric Cardiac Surgery
Open Access
  • Journal of Bioscience & Biomedical Engineering
  • Nov 22, 2021
Relevant
Not Relevant
Biological Reset and Chronic Glaucoma Healing
Open Access
  • Journal of Bioscience & Biomedical Engineering
  • Nov 8, 2021
Relevant
Not Relevant
COVID-19-Vaccination Prioritization in Patients with Cancer
Open Access
  • Journal of Bioscience & Biomedical Engineering
  • Nov 4, 2021
Relevant
Not Relevant
Design and Analysis of Mechanical Microswimmers
Open Access
  • Journal of Bioscience & Biomedical Engineering
  • Nov 4, 2021
Relevant
Not Relevant
Mathematical Multiobjective Optimization for Metal Hip Arthroplasty with Medical Physics Applications
Open Access
  • Journal of Bioscience & Biomedical Engineering
  • Oct 28, 2021
Relevant
Not Relevant
Stimulation Impact of Rhizospheric Microbe’s Glomeromycota AM Fungi and Plant Growth Promoting Rhizobacteria on Growth, Productivity, Lycopene, Β-Carotene, Antioxidant Activity and Mineral Contents of Tomato beneath Field Condition Cultivated in Western Ghats Covering Semi-Arid Region of Maharashtra, India
Open Access
  • Journal of Bioscience & Biomedical Engineering
  • Oct 10, 2021
Relevant
Not Relevant
Total Phenols, Identification of Active Compounds and Anticancer Activity of Salvia judaica Boiss against the breast Cancer Cell MDA-231
Open Access
  • Journal of Bioscience & Biomedical Engineering
  • Oct 8, 2021
Relevant
Not Relevant
A Meta-Analysis Study on Alzheimer’s Disease
  • Journal of Bioscience & Biomedical Engineering
  • Aug 13, 2021
Relevant
Not Relevant